A Study of the Effect of Chronic Inflammation on Exercise Responsiveness

Overview

About this study

The purpose of this study is to determine how chronic inflammation influences skeletal muscle protein metabolism and metabolic function in humans.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Age 30-55 years
  • BMI 19-45 kg/m2

Exclusion Criteria

  • Anemia (female subjects hemoglobin of <11 g/dl and male subjects hemoglobin <12 g/dl)
  • Active coronary artery disease or history of unstable macrovascular disease (unstable angina, myocardial infarction, stroke, and revascularization of coronary, peripheral or carotid artery within 3 months of recruitment)
  • Renal insufficiency/failure (serum creatinine > 1.5mg/dl)
  • Oral warfarin group medications or history of blood clotting disorders
  • Pregnancy or breastfeeding
  • Alcohol consumption greater than 2 glasses/day or other substance abuse
  • Untreated or uncontrolled thyroid disorders
  • Debilitating chronic disease (at the discretion of the investigators)

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ian Lanza, Ph.D.

Open for enrollment

Contact information:

Corey Hart Ph.D.

(507) 255-8147

Hart.Corey@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20267884

Mayo Clinic Footer